Maharashtra FDA Commissioner Tukaram Mundhe states, “Shah Rukh Khan, Ajay Devgn and Tiger Shroff not protected by celeb status in Vimal advertisement case”

Celebrities

Maharashtra Food and Drug Administration (FDA) commissioner Tukaram Mundhe has stated that the star status of Shah Rukh Khan, Ajay Devgn and Tiger Shroff will not safeguard them from regulative action in connection with a Vimal Elaichi ad. The 3 stars were provided show-cause notifications by the Maharashtra FDA after the department mentioned that the ad totaled up to surrogate promo of Vimal Pan Masala, an item restricted in the state.

Maharashtra FDA Commissioner Tukaram Mundhe states,”Shah Rukh Khan, Ajay Devgn and Tiger Shroff not protected by celeb status in Vimal advertisement case”

Talking to NDTV, Mundhe stated the FDA has actually currently progressed with adjudication and prosecution procedures in the event including among the stars who did not react to the notification within the specified duration.

“According to you they might be stars, however according to me they are just marketers in this case. I am looking at them as lawbreakers of the law, and the law will take its own course. That’s why we have actually begun acting,” Mundhe stated.

FDA problems notifications to 3 stars

The Maharashtra FDA provided show-cause notifications to Shah Rukh Khan, Ajay Devgn and Tiger Shroff on August 11, providing 15 days to react. According to Mundhe, 2 of the 3 stars reacted to the notifications, while one did not. He did not recognize which star stopped working to react. “We have actually taken this action according to the law,” Mundhe stated.

He even more exposed that procedures have actually currently started in the event where the star did not send an action. “In one case where they have actually not reacted, we are beginning the adjudicating and prosecution procedures,” he stated.

Mundhe was likewise asked whether Shah Rukh Khan’s group had actually reacted to the notification. He stated, “Most most likely he has actually not reacted, however I’m not too sure about it.”

Stars point out producer’s duty

According to Mundhe, the 2 stars who reacted to the FDA notifications argued that the duty must lie with the maker. The commissioner stated their actions will be thought about throughout the hearing procedure. “We are providing a hearing. My officer, the assistant commissioner who released the notifications, will be providing the hearing,” he stated.

Mundhe, nevertheless, declined the argument that celebs backing an item have no obligation when the producer is accountable for its production and sale.

“There are plainly promoting policies according to the Food Safety Act. [The regulations] discuss who the marketer is, and there is an obligation really particularly cast upon the individual or organization who is marketing. There is an obligation cast upon the individual who is promoting it, consisting of to take due diligence about what she or he is backing. To state that it is not upon them is incorrect … Not just ethically, however lawfully I’m discussing, since I am here as a regulator,” he stated.

The FDA’s action originates from its view that the Vimal Elaichi ad was a type of surrogate promo for Vimal Pan Masala. Surrogate marketing describes the promo of a limited or restricted item through another item or brand name related to it.

Check Out: Bipasha Basu looks for Tukaram Mundhe’s aid after she discovers worms in protein powder: “You are our only hope”

Tags: Ajay Devgn, Controversy, FDA, Maharashtra Food and Drug Administration, Maharashtra Food and Drug Administration (FDA), News, Shah Rukh Khan, Tiger Shroff, Tukaram Mundhe, Vimal Elaichi, Vimal Elaichi debate

BOLLYWOOD NEWS – LIVE UPDATES

Capture us for most current Bollywood News, New Bollywood Movies upgrade, Box workplace collection, New Movies Release, Bollywood News Hindi, Entertainment News, Bollywood Live News Today & Upcoming Movies 2026 and remain upgraded with newest hindi motion pictures just on Bollywood Hungama.


Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND

Subscribe to get the latest posts sent to your email.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here